자동 면역측정 분석기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Automated Immunoassay Analyzers Market size is expected to reach USD 131.23 Billion in 2034 from USD 32.76 Billion (2025) growing at a CAGR of 16.67% during 2026-2034.

The global automated immunoassay analyzers market is expanding rapidly due to the growing demand for accurate and efficient diagnostic testing. These analyzers are widely used in clinical laboratories to detect various diseases, including infectious diseases, cancer, and hormonal disorders. The increasing prevalence of chronic and infectious diseases worldwide is significantly boosting the need for high-throughput diagnostic systems. Additionally, the rising focus on early disease detection and preventive healthcare is encouraging healthcare facilities to adopt automated immunoassay technologies.

Technological innovations are playing a crucial role in strengthening market growth. Modern analyzers offer improved sensitivity, faster processing times, and enhanced automation capabilities, which help laboratories handle large volumes of tests with minimal human intervention. Integration of advanced software, data management systems, and artificial intelligence is also improving diagnostic accuracy and workflow efficiency. Furthermore, the expansion of diagnostic laboratories and hospitals in developing countries is contributing to increased adoption of automated immunoassay analyzers.

Looking ahead, the automated immunoassay analyzers market is expected to grow steadily as healthcare systems prioritize efficient diagnostics and personalized medicine. Increasing investments in laboratory automation and growing research activities in biotechnology and pharmaceuticals are likely to create new opportunities for manufacturers. In addition, rising demand for point-of-care testing and advanced laboratory equipment will continue to drive technological advancements and market expansion in the years to come.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Outright Sale
• Reagent Rental/Lease

By End-User

• Diagnostic Laboratories
• Hospitals
• Blood Bank

By Technology

• Enzyme-Linked Fluorescent Immunoassay (ELFA)
• Chemiluminescence Immunoassay (CLIA)
• Radioimmunoassay (RIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)

COMPANIES PROFILED

• BioRad Laboratories, Roche Diagnostics AG, Siemens Healthcare, Carolina Liquid Chemistries Corporation, Ortho Clinical Diagnostics Corporation, Meril Life Sciences, Becton Dickinson and Company, Luminex Corporation, Abbott Laboratories, Randox Laboratories, BioMerieux SA, Arlington Scientific, Aesku Diagnostics, PerkinElmer Inc, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Outright Sale Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Rental/Lease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Blood Bank Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Enzyme-Linked Fluorescent Immunoassay (ELFA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chemiluminescence Immunoassay (CLIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Radioimmunoassay (RIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By End-user
  • 7.2.3 By Technology
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By End-user
  • 7.3.3 By Technology
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By End-user
  • 7.4.3 By Technology
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By End-user
  • 7.5.3 By Technology
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By End-user
  • 7.6.3 By Technology
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BioRad Laboratories
  • 9.2.2 Roche Diagnostics AG
  • 9.2.3 Siemens Healthcare
  • 9.2.4 Carolina Liquid Chemistries Corporation
  • 9.2.5 Ortho Clinical Diagnostics Corporation
  • 9.2.6 Meril Life Sciences
  • 9.2.7 Becton Dickinson And Company
  • 9.2.8 Luminex Corporation
  • 9.2.9 Abbott Laboratories
  • 9.2.10 Randox Laboratories
  • 9.2.11 BioMerieux S.A
  • 9.2.12 Arlington Scientific
  • 9.2.13 Aesku Diagnostics
  • 9.2.14 PerkinElmer Inc
  • 9.2.15 F. Hoffmann-La Roche Ltd